香港货币及金融研究中心：人口高龄化令长线投资成当务之急 编辑：徐世明 广告等商务合作，请点击这里 中新网香港9月23日电 香港金融学院辖下负责研究工作的香港货币及金融研究中心22日发表"香港长线 投资：数字经济下的发展及机遇"应用金融研究报告显示，香港居民具备良好的基础理财知识，但仍需 加深对特定金融产品的了解，尤其是与长线投资及财务规划有关的产品。 本文为转载内容，授权事宜请联系原著作权人 研究指出，香港市场上已存在不少多样化及具有全球竞争力的财富累积产品，但67%受访机构认为，市 场仍需要更多具备财富提取功能的产品选择，以满足客户对长线财务规划的需求。 研究报告进一步探讨业界如何促进香港长线投资生态圈的健康发展。其中，采用前沿技术是推动创新产 品和服务、提高成本效益、优化产品分销，以提升长线投资和财务规划方面发展的关键。 香港金融学院行政总裁兼研究中心执行董事冯殷诺表示，人口高龄化趋势持续，长线投资成为当务之 急。该研究成果将为市场参与者提供有价值的参考，帮助他们应对现有的挑战、把握商机，从而推动香 港长线投资生态圈朝着更全面、更健康的方向发展。(完) 来源：中国新闻网 中新经纬版权所有，未经书面授权，任 ...

此外，研究结果反映，受访者数码采用率日趋普及。72%受访居民表示过去一年曾使用数码金融服务， 而约70%受访市场参与者表示，他们正在或计划通过流动和网络平台分销长线理财产品。 新华财经香港9月22日电（记者林迎楠）香港金融学院辖下负责研究工作的香港货币及金融研究中心22 日发表题为"香港长线投资：数字经济下的发展及机遇"的应用金融研究报告显示，采用前沿技术是推动 创新产品和服务、提高成本效益、优化产品分销，以提升长线投资和财务规划方面发展的关键。 据悉，报告以研究中心过往对人口结构转变及长线资产市场的研究为基础，并在数字经济日新月异的背 景下，对香港的长线投资格局及机遇作出全面及最新的分析。 研究结果显示，尽管香港居民具备良好的基础理财知识，但仍需要加深对特定金融产品的了解，尤其是 与长线投资及财务规划有关的产品。在产品方面，目前香港市场上已存在不少多样化及具有全球竞争力 的财富累积产品，但67%受访机构认为，市场仍需要更多具备财富提取功能的产品选择，以满足客户对 长线财务规划的需求。 根据调查所得，研究报告进一步探讨业界如何促进香港长线投资生态圈的健康发展。其中，采用前沿技 术是推动创新产品和服务、提高成本 ...

Group 1 - The core trading rule for A-shares is the T + 1 system, meaning stocks cannot be sold on the same day they are purchased, and the earliest they can be sold is the next trading day [3] - The actual holding period for stocks depends on the investor's strategy and market conditions, with common extremes being either selling too early or holding too long without a clear exit strategy [4][10] Group 2 - Short-term trading typically involves holding stocks for a few days to a couple of weeks, focusing on capturing short-term price fluctuations and news events [6] - Medium-term investing usually spans several weeks to months, relying on industry trends and company fundamentals, with the challenge being to accurately identify trend reversals [7] - Long-term investing emphasizes the company's long-term value, with holding periods often exceeding six months or even years, and selling decisions based on fundamental deterioration or changes in industry logic [9]

Core Viewpoint - The most important aspects of investing in the pharmaceutical industry are passion, focus, and honesty, which serve as foundational elements for building a robust investment framework [1][10]. Group 1: Importance of Passion - Passion provides an intrinsic motivation that sustains long-term engagement in investment, as opposed to external goals like profit [2][3]. - The transition from individual to institutional investor can enhance the sense of purpose and value recognition in pharmaceutical investments [2]. - A strong desire for a better future drives continuous learning and exploration, leading to meaningful changes in investment strategies [3]. Group 2: Focus and Comparative Advantage - The evolution of society towards greater specialization emphasizes the need for individuals to focus on their strengths to enhance efficiency and value [6]. - Accumulating comparative advantages requires a clear understanding of personal strengths and market dynamics [6]. - The optimal investment strategy involves identifying undervalued assets that the market currently overlooks but will recognize in the future [6][7]. Group 3: Industry Research and Trends - A reliable industry research framework is essential for predicting the future of companies within the pharmaceutical sector [7]. - The Chinese healthcare reform since 2015 mirrors the U.S. reforms of the 1980s, creating opportunities for innovative pharmaceutical products while pressuring traditional models [8]. - Understanding technological trends, such as advancements in antibody products and gene editing, is crucial for identifying investment opportunities [8]. Group 4: Valuation and Investment Strategy - A robust valuation framework is necessary to identify truly undervalued assets rather than simply reacting to price declines [9]. - The investment focus may shift from a heavy emphasis on research frameworks to developing a more efficient investment allocation strategy [9]. - The investment strategy will prioritize long-term, value-driven investments while remaining adaptable to market changes [9]. Group 5: Continuous Improvement through Honesty - Acknowledging personal limitations and errors is vital for maintaining a realistic perspective on market risks and opportunities [10][11]. - Building a solid foundational framework allows for the effective integration of external viewpoints and insights [10][11]. - The process of learning from past experiences, especially during market downturns, can lead to significant improvements in investment strategies [12]. Group 6: Market Dynamics and Cycles - Understanding macroeconomic trends is essential for navigating the cyclical nature of the pharmaceutical sector [13]. - Recognizing the impact of market sentiment and narrative shifts on stock prices can inform better investment decisions [14][15]. - The distinction between strategic and tactical holdings is crucial for managing investment portfolios effectively [14].